The significantly higher efficacy of once-weekly insulin icodec compared to once- daily Insulin Glargine U-100 that it may be a preferred option for achieving excellent glycemic control in patients with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.